NYSE:CO - China Cord Blood Stock Price, Price Target & More

Get Started

$9.44 -0.02 (-0.21 %)

(As of 05/21/2018 04:00 PM ET)

Previous Close$9.46

Today's Range$9.41 - $9.56

52-Week Range$7.40 - $14.95

Volume60,400 shs

Average Volume226,893 shs

Market Capitalization$1.14 billion

P/E Ratio27.82

Dividend YieldN/A

Beta0.93

About China Cord Blood (NYSE:CO)

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2017, it had three operating cord blood banks in the Beijing municipality, the Guangdong province, and the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. As of January 31, 2018, Global Cord Blood Corporation operates as a subsidiary of Nanjing Ying Peng Hui Kang Medical Industry Investment Partnership (Limited Partnership).

Receive CO News and Ratings via Email

Sign-up to receive the latest news and ratings for CO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Holding & other investment offices

Sub-IndustryN/A

SectorMedical

SymbolNYSE:CO

CUSIPN/A

Webwww.chinacordbloodcorp.com

Phone852-3605-8180

Debt

Debt-to-Equity RatioN/A

Current Ratio9.28

Quick Ratio9.20

Price-To-Earnings

Trailing P/E Ratio27.82

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$110.41 million

Price / Sales10.31

Cash Flow$0.3269 per share

Price / Cash28.88

Book Value$3.34 per share

Price / Book2.83

Profitability

EPS (Most Recent Fiscal Year)N/A

Net Income$18.33 million

Net Margins27.05%

Return on Equity9.05%

Return on Assets4.49%

Miscellaneous

Employees1,059

Outstanding Shares120,610,000

China Cord Blood (NYSE:CO) Frequently Asked Questions

What is China Cord Blood's stock symbol?

China Cord Blood trades on the New York Stock Exchange (NYSE) under the ticker symbol "CO."

How were China Cord Blood's earnings last quarter?

China Cord Blood (NYSE:CO) issued its quarterly earnings data on Monday, February, 26th. The medical research company reported $0.09 earnings per share (EPS) for the quarter. The medical research company had revenue of $37.65 million for the quarter. China Cord Blood had a net margin of 27.05% and a return on equity of 9.05%. View China Cord Blood's Earnings History.

When is China Cord Blood's next earnings date?

China Cord Blood is scheduled to release their next quarterly earnings announcement on Wednesday, June, 20th 2018. View Earnings Estimates for China Cord Blood.

Who are some of China Cord Blood's key competitors?

Some companies that are related to China Cord Blood include Alta Mesa Resources (AMR), TPG Pace Energy (TPGE), GTY Technology (GTYH), Vantage Energy (VEAC), Pensare Acquisition (WRLS), AgroFresh Solutions (AGFS), Modern Media Acquisition (MMDM), KBL Merger Corp IV (KBLM), STELLAR ACQUISI/SH SH (STLR), TMSR (TMSR), JENSYN ACQUISIT/SH (JSYN), JetPay (JTPY), UPD (UPDC), STG Group (STGG) and Sandston (SDON).

Who are China Cord Blood's key executives?

China Cord Blood's management team includes the folowing people:

Ms. Ting Zheng, Chairman, CEO & Interim CEO of Beijing Division (Age 46)
Mr. Albert Chen, CFO, Chief Accounting Officer & Director (Age 42)
Ms. Xin Xu, Chief Technology Officer (Age 64)
Ms. Rui Arashiyama, Chief Exec. Officer of Guangdong Division & Zhejiang Division (Age 59)

Has China Cord Blood been receiving favorable news coverage?

News stories about CO stock have been trending somewhat positive this week, Accern Sentiment Analysis reports. Accern scores the sentiment of news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. China Cord Blood earned a news impact score of 0.09 on Accern's scale. They also assigned press coverage about the medical research company an impact score of 46.10 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the near term.

Who are China Cord Blood's major shareholders?

China Cord Blood's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Millennium Management LLC (0.14%), Citadel Advisors LLC (0.07%), Wells Fargo & Company MN (0.07%), California Public Employees Retirement System (0.05%), Parametrica Management Ltd (0.05%) and Dumac Inc. (0.02%). View Institutional Ownership Trends for China Cord Blood.

Which institutional investors are selling China Cord Blood stock?

CO stock was sold by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN and JPMorgan Chase & Co.. View Insider Buying and Selling for China Cord Blood.

Which institutional investors are buying China Cord Blood stock?

CO stock was acquired by a variety of institutional investors in the last quarter, including California Public Employees Retirement System, Millennium Management LLC, Parametrica Management Ltd, Dumac Inc., Element Capital Management LLC, Citadel Advisors LLC, Cubist Systematic Strategies LLC and Russell Investments Group Ltd.. View Insider Buying and Selling for China Cord Blood.

How do I buy shares of China Cord Blood?

Shares of CO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is China Cord Blood's stock price today?

One share of CO stock can currently be purchased for approximately $9.44.

How big of a company is China Cord Blood?

China Cord Blood has a market capitalization of $1.14 billion and generates $110.41 million in revenue each year. China Cord Blood employs 1,059 workers across the globe.

How can I contact China Cord Blood?

China Cord Blood's mailing address is 48TH FLOOR BANK OF CHINA TOWER 1 GARDEN ROAD, HONG KONG K3, . The medical research company can be reached via phone at 852-3605-8180 or via email at [email protected]

MarketBeat Community Rating for China Cord Blood (CO)

Community Ranking:		2.3 out of 5 ( )
Outperform Votes:		136 (Vote Outperform)
Underperform Votes:		161 (Vote Underperform)
Total Votes:		297

MarketBeat's community ratings are surveys of what our community members think about China Cord Blood and other stocks. Vote "Outperform" if you believe CO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CO will underperform the S&P 500 over the long term. You may vote once every thirty days.

China Cord Blood (NYSE:CO) Analyst Ratings History

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price	Details

(Data available from 5/21/2016 forward)

China Cord Blood (NYSE:CO) Earnings History and Estimates Chart

Earnings by Quarter for China Cord Blood (NYSE:CO)

China Cord Blood (NYSE CO) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
6/19/2018		$0.13					N/A
2/26/2018	Q3 2018		$0.09		$37.65 million	View	N/A
11/20/2017	Q2 2018		$0.09		$35.26 million	View	N/A
8/23/2017	6/30/2017		$0.09		$33.07 million	View	N/A
6/21/2017	3/31/2017	$0.05	$0.07		$29.35 million	View	N/A
2/24/2017	Q317	$0.04	$0.10		$28.93 million	View	Listen
11/17/2016	Q217	$0.04	$0.03	$27.37 million	$27.61 million	View	Listen
8/22/2016	Q117	$0.03	$0.03	$26.23 million	$26.00 million	View	N/A
6/14/2016	Q416	$0.03	$0.03	$25.87 million	$24.31 million	View	Listen
2/29/2016	Q3 2016	$0.05	$0.10	$26.97 million	$26.15 million	View	N/A
11/23/2015	Q216	$0.04	$0.05	$26.42 million	$27.00 million	View	Listen
8/19/2015	Q116	$0.04	$0.03	$25.81 million	$26.70 million	View	Listen
6/18/2015	Q415	$0.05	$0.04	$25.88 million	$26.30 million	View	Listen
2/25/2015	Q315	$0.06	$0.07	$26.35 million	$26.90 million	View	Listen
11/25/2014	Q2	$0.06	$0.06	$25.30 million	$24.78 million	View	Listen
8/28/2014	Q1	$0.06	$0.06	$24.78 million	$24.72 million	View	Listen
6/18/2014	Q414	$0.07	$0.07	$24.41 million	$24.44 million	View	N/A
2/24/2014	Q3	$0.06	$0.07	$24.22 million	$24.90 million	View	Listen
1/31/2014	Q4		($0.25)			View	N/A
11/15/2013	Q2	$0.06	$0.06	$22.32 million	$23.10 million	View	Listen
8/26/2013	Q1 2014	$0.04	$0.07	$21.62 million	$21.00 million	View	Listen
6/18/2013	Q4 2013	$0.02	$0.05	$16.59 million	$21.40 million	View	Listen
2/26/2013	Q3 2013	$0.05	$0.07			View	N/A
11/19/2012	Q312		$0.05	$18.53 million	$20.40 million	View	N/A
8/22/2012	Q1 2013	$0.04	$0.06			View	N/A
6/11/2012	Q4 2012	$0.06	$0.06			View	N/A
2/27/2012	Q3 2012	$0.06	$0.09			View	N/A
11/28/2011	Q2 2012	$0.06	$0.05			View	N/A
8/29/2011	Q1 2012	$0.05	$0.08			View	N/A
6/10/2011	Q4 2011	$0.05	$0.05			View	N/A
2/28/2011	Q3 2011	$0.04	$0.06			View	N/A
11/24/2010	Q2 2011	$0.04	$0.05			View	N/A
9/10/2010	Q1 2011	$0.04	$0.04			View	N/A
6/22/2010	Q4 2010	$0.04	$0.03			View	N/A
3/5/2010	Q2 2010		$0.04			View	N/A
12/11/2009	Q1 2010		$0.04			View	N/A

(Earnings results data provided by Zacks Investment Research)

China Cord Blood (NYSE:CO) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date

(Data available from 1/1/2013 forward)

China Cord Blood (NYSE CO) Insider Trading and Institutional Ownership History

Institutional Ownership Percentage: 19.81%

Insider Trading History for China Cord Blood (NYSE:CO)

Institutional Ownership by Quarter for China Cord Blood (NYSE:CO)

China Cord Blood (NYSE CO) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
1/5/2016	Gordon Scott Townsen Mckinnon	Director	Buy	500,000	$0.02	$10,000.00
9/30/2015	Fraser James Laschinger	Insider	Buy	80,000	$0.0150	$1,200.00
9/30/2015	Gordon Scott Townsen Mckinnon	Director	Buy	50,000	$0.0150	$750.00
9/29/2015	Gordon Scott Townsen Mckinnon	Director	Buy	1,000	$0.0250	$25.00
1/21/2015	Kent C Mccarthy	Insider	Buy	20,000	$4.60	$92,000.00
1/16/2015	Kent C Mccarthy	Insider	Buy	50,000	$4.30	$215,000.00
1/14/2015	Private Equity Fund Jayhawk II	Insider	Buy	10,000	$4.52	$45,200.00
1/12/2015	Private Equity Fund Jayhawk II	Insider	Buy	50,000	$4.69	$234,500.00
11/28/2014	Robert Douglas Cudney	Insider	Buy	200,000	$0.0050	$1,000.00
11/17/2014	Kent C Mccarthy	Insider	Buy	26,754	$4.70	$125,743.80
11/6/2014	Kent C Mccarthy	Insider	Buy	150,000	$5.16	$774,000.00
9/29/2014	Kent C Mccarthy	Insider	Buy	10,000	$5.00	$50,000.00
9/10/2014	Kent C Mccarthy	Insider	Buy	9,900	$4.98	$49,302.00

(Data available from 1/1/2013 forward)

China Cord Blood (NYSE CO) News Headlines

Source:

Date	Headline
	Venus Medtech Receives DCP Capital's Equity Investment to Accelerate Heart Valve Technology Development and International Commercialization www.bizjournals.com - May 17 at 9:52 AM
	Two surgeons in China developing a method to transplant a human head www.cnbc.com - May 15 at 10:11 AM
	See what the IHS Markit Score report has to say about Global Cord Blood Corp. finance.yahoo.com - May 9 at 9:40 AM
	Contrasting JetPay (JTPY) and China Cord Blood (CO) www.americanbankingnews.com - May 2 at 5:38 AM
	Head-To-Head Analysis: China Cord Blood (CO) versus AgroFresh Solutions (AGFS) www.americanbankingnews.com - April 28 at 11:10 PM
	Critical Comparison: China Cord Blood (CO) and AgroFresh Solutions (AGFS) www.americanbankingnews.com - April 27 at 7:22 PM
	ConvergeOne (CVON) versus China Cord Blood (CO) Head-To-Head Comparison www.americanbankingnews.com - April 25 at 10:03 AM
	China Cord Blood (CO) Lifted to Strong-Buy at BidaskClub www.americanbankingnews.com - April 14 at 6:22 PM
	Universal Business Payment Solutions Acquisition (JTPY) vs. China Cord Blood (CO) Critical Survey www.americanbankingnews.com - April 14 at 5:43 AM
	China Cord Blood (CO) vs. AgroFresh Solutions (AGFS) Head-To-Head Review www.americanbankingnews.com - April 10 at 9:34 PM
	Analyzing China Cord Blood (CO) & ConvergeOne (CVON) www.americanbankingnews.com - April 10 at 7:09 PM
	Financial Analysis: AgroFresh Solutions (AGFS) and China Cord Blood (CO) www.americanbankingnews.com - April 4 at 3:20 PM
	Head-To-Head Survey: AgroFresh Solutions (AGFS) versus China Cord Blood (CO) www.americanbankingnews.com - April 2 at 3:06 AM
	Cord Blood Banking Market to Gain From Enhanced Application in Genetic Disease Treatment: Radiant Insights, Inc. finance.yahoo.com - March 27 at 10:07 AM
	BRIEF-Nanjing Xinjiekou Department Store Clarifies Media Reports On Investment In Unit China Cord Blood finance.yahoo.com - March 23 at 9:35 AM
	BRIEF-China Cord Blood Says Shareholders Approved Co's Name Change www.reuters.com - March 16 at 5:14 PM
	China Cord Blood to become Global Cord Blood March 22 seekingalpha.com - March 16 at 5:14 PM
	Should You Be Tempted To Sell China Cord Blood Corporation (NYSE:CO) At Its Current PE Ratio? finance.yahoo.com - March 16 at 5:14 PM
	China Cord Blood Corporation Announces Results of Extraordinary General Meeting of Shareholders to Change Company Name to "Global Cord Blood Corporation" finance.yahoo.com - March 16 at 9:58 AM
	Quinn Opportunity Partners LLC Has $1.01 Million Holdings in China Cord Blood Corp (CO) www.americanbankingnews.com - March 5 at 12:34 PM
	China Cord Blood Corp (CO) Shares Bought by Arrowstreet Capital Limited Partnership www.americanbankingnews.com - March 3 at 4:24 AM
	China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2018 finance.yahoo.com - February 26 at 4:50 PM
	How Does China Cord Blood Corporation’s (NYSE:CO) Earnings Growth Stack Up Against Industry Performance? finance.yahoo.com - February 26 at 4:50 PM
	China Cord Blood (CO) to Release Quarterly Earnings on Thursday www.americanbankingnews.com - February 15 at 1:44 AM
	China Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2018 Financial Results finance.yahoo.com - February 14 at 9:03 AM
	China Cord Blood Corporation to Change Corporate Name to "Global Cord Blood Corporation" finance.yahoo.com - February 7 at 9:05 AM
	Tempted to buy on sell-off? Pick a stock you like, says C... finance.yahoo.com - February 6 at 4:31 PM
	Golden Meditech Acquires 16.14% Interest of Ying Peng Hui Kang Fund www.bizjournals.com - February 5 at 9:01 AM
	Nanjing Ying Peng Becomes Major Shareholder of China Cord Blood Corporation finance.yahoo.com - January 31 at 9:16 AM
	Golden Meditech Completes Sale of Equity Interest in China Cord Blood Corporation www.prnewswire.com - January 31 at 5:00 AM
	Contrasting China Cord Blood (CO) and Laboratory Corp. of America (LH) www.americanbankingnews.com - January 25 at 3:12 AM
	Oversold Conditions For China Cord Blood (CO) www.nasdaq.com - January 12 at 5:01 PM
	China Cord Blood (CO) and Select Medical (SEM) Head-To-Head Comparison www.americanbankingnews.com - January 12 at 3:28 PM
	China Cord Blood (CO) versus Laboratory Corp. of America (LH) Critical Comparison www.americanbankingnews.com - January 10 at 7:40 PM
	Comparing China Cord Blood (CO) & The Providence Service (PRSC) www.americanbankingnews.com - January 8 at 5:34 AM
	ETFs with exposure to China Cord Blood Corp. : December 25, 2017 finance.yahoo.com - December 25 at 6:58 PM
	How A Young Danish Speaker Startup Took Off finance.yahoo.com - December 19 at 9:40 AM
	China Cord Blood Corp. :CO-US: Earnings Analysis: Q2, 2018 By the Numbers : December 18, 2017 finance.yahoo.com - December 18 at 5:09 PM
	ETFs with exposure to China Cord Blood Corp. : December 13, 2017 finance.yahoo.com - December 13 at 5:22 PM
	China Cord Blood (CO) versus HMS (HMSY) Critical Comparison www.americanbankingnews.com - December 11 at 7:16 PM
	China Cord Blood Corporation Announces Results of 2017 Annual General Meeting finance.yahoo.com - December 7 at 9:56 AM
	Will China Cord Blood Corporation (CO) Continue To Underperform Its Industry? finance.yahoo.com - December 6 at 5:13 PM
	China Cord Blood Corp. – Value Analysis (NYSE:CO) : November 24, 2017 finance.yahoo.com - November 24 at 3:58 PM
	Surgical Care Affiliates (SCAI) & China Cord Blood Corporation (CO) Head to Head Contrast www.americanbankingnews.com - November 23 at 3:36 PM
	China Cord Blood Corporation to Host Earnings Call finance.yahoo.com - November 23 at 4:10 AM
	China Cord Blood Corp. breached its 50 day moving average in a Bullish Manner : CO-US : November 22, 2017 finance.yahoo.com - November 22 at 6:05 PM
	Edited Transcript of CO earnings conference call or presentation 21-Nov-17 1:00pm GMT finance.yahoo.com - November 21 at 10:36 PM
	China Cord Blood's (CO) Management on Q2 2018 Results - Earnings Call Transcript seekingalpha.com - November 21 at 5:33 PM
	China Cord Blood Corp Reports 306% Advance In Q2 Earnings www.rttnews.com - November 20 at 6:28 PM
	China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2018 finance.yahoo.com - November 20 at 6:28 PM

China Cord Blood (NYSE:CO) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

China Cord Blood (NYSE:CO) Income Statement, Balance Sheet and Cash Flow Statement

China Cord Blood (NYSE CO) Stock Chart for Monday, May, 21, 2018

Loading chart…

This page was last updated on 5/21/2018 by MarketBeat.com Staff